1111P Suboptimal real-world (RW) outcomes for BRAF+ metastatic melanoma (MM) patients in 2L therapy (The NOBLE study series) A.A. Tarhini,A. Betof Warner,M. Johnson,B. Kang, A. Nakasato,M. Vance,Y-L. Ling,J. Tang,J. PatelAnnals of Oncology(2020)引用 0|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要